Lidamycin inhibits angiogenesis of zebrafish embryo via down-regulation of VEGF

Yaoxue Xuebao

Volumn 45, Issue 4, 2010, Pages 456-461

  Ding, Li Li ^a,b   Liu, Ming ^a   Zhang, Sheng Hua ^c   Zhao, Xiang Zhong ^a,b   Wu, Ning ^a,b   Chen, Lei ^a,b   Wang, Guang Jian ^a   Lin, Xiu Kun ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Angiogenesis; Lidamycin; Vascular endothelial growth factor; Zebrafish

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; LIDAMYCIN; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; EMBRYO; ERYTHROCYTE; ERYTHROCYTE COUNT; HEART EDEMA; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING; ZEBRA FISH;

AMINOGLYCOSIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBIOTICS, ANTINEOPLASTIC; DOWN-REGULATION; EMBRYO, NONMAMMALIAN; ENEDIYNES; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

EID: 77951572778     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ferrara N, Hillan KJ, Gerber HP, et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J]. Nat Rev Drug Discov, 2004, 3: 391-400. (Pubitemid 38618122)
2. Pichler FB, Laurenson S, Williams LC, et al. Chemical discovery and global gene expression analysis in zebrafish [J]. Nat Biotechnol, 2003, 21: 879-883. (Pubitemid 36936192)
3. Jin SW, Beis D, Mitchell T, et al. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish [J]. Development, 2005, 132: 5199-5209. (Pubitemid 43020175)
4. Yang SL, Yan S, Lin XK, et al. Suppression of zebrafish VEGF gene by cytomegalovirus promoter-driven short hairpin constructs induces vascular development defects and down regulation NRP1 expression [J]. Biologia, 2009, 64: 1025-1031.
5. Zheng LH, Wang Z, Lin XK, et al. A novel peptide from shark cartilage with potent antiangiogenesis activity [J]. Cancer Biol Ther, 2007, 6: 775-780. (Pubitemid 47328361)
6. Wang Z, Zheng LH, Lin XK, et al. N-Acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro [J]. Biochem Biophys Res Commun, 2007, 357: 26-31. (Pubitemid 46574495)
7. Shao RG, Zhen YS. Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology [J]. Anti Cancer Agents Med Chem, 2008, 8:123-131.
8. Wang XH, Wu SY, Zhen YS. Lidamycin inhibits proliferation and induces apoptosis in endothelial cells [J]. Chin J Antibiot, 2003, 28: 605-612. (Pubitemid 38016842)
9. Ou-yang ZG, Zhen YS. Antiangiogenic effects of lidamycin and mechanism of actin [C]. Oncol Res, 2006, 15: 474-474
10. Zhen HY, Xue YC, Zhen YS. Inhibition of angiogenesis is by antitumor antibiotic C1027 and its effect on tumor metastasis [J]. Natl Med J China, 1997, 77: 657-660.
11. Parng C, Seng WL, Semino C, et al. Zebrafish: a preclinical model for drug screening [J]. Assay Drug Dev Technol, 2002, 1: 41-48.
12. Habeck H, Odenthal J, Walderich B, et al. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis [J]. Curr Biol, 2002, 12: 1405-1412. (Pubitemid 34915543)
13. Zhen YS, Ming XY, Yu B, et al. A new macromolecular antitumor antibiotic. C-1027, III. antitumor activity [J]. J Antibiot (Tokyo), 1989, 42:1294-1298. (Pubitemid 19212674)
14. Qiu Q, Wang Z, Jiang JM, et al. Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells [J]. Acta Pharm Sin, 2007, 42: 132-138.
15. Zhang SH, Chen J, Jiang M, et al. Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice [J]. Acta Pharm Sin, 2008, 43: 601-604.
16. Sakata N, Tsuchiya KS, Moriya Y, et al. Aminopeptidase activity of an antitumor antibiotic, C-1027 [J]. J Antibiot, 1992, 45: 113-117.
17. Otani T, Yasuhara T, Minami Y, et al. Purification and primary structure of C-1027-AG, a selective antagonist of antitumor antibiotic C-1027, from Streptomyces-globisporus [J]. Agric biol Chem, 1991, 55: 407-417.
18. Xu F, Ou-yang ZG, Zhang SH, et al. Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells [J]. Acta Pharm Sin, 2006, 41: 572-576. (Pubitemid 44174288)
19. Tokuyama J, Kubota T, Saikawa Y, et al. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis [J]. Anticancer Res, 2005, 25: 17-22.